Criteria for selective screening for Chlamydia trachomatis. 2003

Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
Department of Obstetrics and Gynecology and Haartman Institute, University of Helsinki, Finland. Maarit.Paukku@hus.fi

BACKGROUND On the basis of studies in ethnically diverse populations, it appears that the best strategy for prevention of infections is screening of all women aged 25 years or younger. OBJECTIVE The goal was to determine screening criteria in an ethnically and socioeconomically homogenous population with low prevalence of genital chlamydia infection. METHODS Women (N = 1198) attending two family planning clinics were screened for and surveyed for risk factors. Data were analyzed with multivariate logistic regression. RESULTS The overall prevalence of infection was 3.5%. Risk markers for the infection included marital status, number of sex partners, and age. Screening women aged 25 years or younger would have identified 28% of all chlamydial infections, while screening all women aged 30 years or younger would have identified 83% of infections. CONCLUSIONS Because of its feasibility, age appears to still be the best screening criterion. However, extension of the screening to include women up to 30 years of age should be considered.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D002692 Chlamydia trachomatis Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
April 1986, JAMA,
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
September 1999, European journal of obstetrics, gynecology, and reproductive biology,
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
July 2012, BMJ (Clinical research ed.),
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
December 1997, Ugeskrift for laeger,
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
August 1997, Ugeskrift for laeger,
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
April 2007, BMJ (Clinical research ed.),
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
October 2000, Sexually transmitted infections,
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
March 1997, Sexually transmitted diseases,
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
February 2005, Sexually transmitted infections,
Maarit Paukku, and Riika Kilpikari, and Mirja Puolakkainen, and Hanna Oksanen, and Dan Apter, and Jorma Paavonen
September 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Copied contents to your clipboard!